Precision medicine for obesity: current evidence and insights for personalization of obesity pharmacotherapy
Obesity is a chronic and complex disease associated with increased morbidity, mortality,
and financial burden. It is expected that by 2030 one of two people in the United States will …
and financial burden. It is expected that by 2030 one of two people in the United States will …
[HTML][HTML] Sizing up pharmacotherapy for obesity
MA Valentino, A Terzic, SA Waldman - Clinical and translational …, 2010 - ncbi.nlm.nih.gov
Obesity has increased over the last 20 years, from a condition affecting only a small portion
of populations in developed countries, into a global pandemic. 1 The impact of obesity can …
of populations in developed countries, into a global pandemic. 1 The impact of obesity can …
Pharmacotherapy of obesity: an update on the available medications and drugs under investigation
M Chakhtoura, R Haber, M Ghezzawi, C Rhayem… - …, 2023 - thelancet.com
Obesity is an epidemic and a public health threat. Medical weight management remains one
of the options for the treatment of excess weight and recent advances have revolutionized …
of the options for the treatment of excess weight and recent advances have revolutionized …
Pharmacotherapy for obesity: moving towards efficacy improvement
W Coutinho, B Halpern - Diabetology & Metabolic Syndrome, 2024 - Springer
Obesity is a chronic, recurring, progressive disease and a major public health problem
associated with several other diseases that lead to disability, morbidity, and mortality. The …
associated with several other diseases that lead to disability, morbidity, and mortality. The …
Current updates in the medical management of obesity
Obesity is a chronic medical condition that is expected to become an indirect but leading
cause of mortality and morbidity. Obesity results in type 2 diabetes mellitus, insulin …
cause of mortality and morbidity. Obesity results in type 2 diabetes mellitus, insulin …
[HTML][HTML] Obesity–Standards, trends and advances
J Gołacki, B Matyjaszek-Matuszek - Advances in Medical Sciences, 2024 - Elsevier
Obesity continues to be a significant global health concern, giving rise to various
complications. This review article explores the current standards and emerging innovations …
complications. This review article explores the current standards and emerging innovations …
Obesity medications: what does the future look like?
WS Butsch - Current Opinion in Endocrinology, Diabetes and …, 2015 - journals.lww.com
To combat the complex physiological system of energy regulation and the known variation of
treatment response, combinatory therapies for obesity, including pharmacotherapy, are …
treatment response, combinatory therapies for obesity, including pharmacotherapy, are …
Beyond weight loss: added benefits could guide the choice of anti-obesity medications
V Guglielmi, S Bettini, P Sbraccia, L Busetto… - Current obesity …, 2023 - Springer
Abstract Purpose of Review To highlight the added benefits of approved and upcoming,
centrally-acting, anti-obesity drugs, focusing not only on the most common metabolic and …
centrally-acting, anti-obesity drugs, focusing not only on the most common metabolic and …
Current pharmacotherapy for obesity
G Srivastava, CM Apovian - Nature Reviews Endocrinology, 2018 - nature.com
More than one-third of adults in the USA have obesity, which causes, exacerbates or
adversely impacts numerous medical comorbidities, including diabetes mellitus and …
adversely impacts numerous medical comorbidities, including diabetes mellitus and …
Obesity: the new global epidemic pharmacological treatment, opportunities and limits for personalized therapy
W Milano, V De Biasio, W Di Munzio… - … Metabolic & Immune …, 2020 - ingentaconnect.com
Background: The increase in global obesity rates over the past three decades has been
remarkable, a true epidemic, both in developed and in developing countries. The …
remarkable, a true epidemic, both in developed and in developing countries. The …